News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,883 Results
Type
Article (87528)
Company Profile (807)
Press Release (774526)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233093)
Career Advice (4140)
Deals (39811)
Drug Delivery (140)
Drug Development (91280)
Employer Resources (203)
FDA (18297)
Job Trends (17407)
News (397484)
Policy (39929)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (130)
Alliances (56980)
ALS (147)
Alzheimer's disease (1691)
Antibody-drug conjugate (ADC) (267)
Approvals (18338)
Artificial intelligence (515)
Autoimmune disease (104)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (139)
Brain cancer (53)
Breast cancer (528)
Cancer (4175)
Cardiovascular disease (361)
Career advice (3562)
Career pathing (38)
CAR-T (258)
CDC (57)
Cell therapy (712)
Cervical cancer (33)
Clinical research (75819)
Collaboration (1448)
Company closure (4)
Compensation (963)
Complete response letters (62)
COVID-19 (2964)
CRISPR (85)
C-suite (627)
Cystic fibrosis (142)
Data (4943)
Decentralized trials (2)
Denatured (64)
Depression (113)
Diabetes (467)
Diagnostics (7111)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (247)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (209)
Earnings (99213)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133522)
Executive appointments (998)
FDA (20893)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1305)
Gene editing (181)
Generative AI (52)
Gene therapy (567)
GLP-1 (1039)
Government (5392)
Grass and pollen (8)
Guidances (374)
Healthcare (20939)
HIV (49)
Huntington's disease (41)
IgA nephropathy (67)
Immunology and inflammation (257)
Immuno-oncology (22)
Indications (59)
Infectious disease (3214)
Inflammatory bowel disease (192)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (199)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10151)
Liver cancer (92)
Longevity (13)
Lung cancer (592)
Lymphoma (286)
Machine learning (33)
Management (66)
Manufacturing (673)
MASH (147)
Medical device (14914)
Medtech (14941)
Mergers & acquisitions (22785)
Metabolic disorders (1193)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (237)
Neuropsychiatric disorders (63)
Neuroscience (2764)
NextGen: Class of 2025 (7687)
Non-profit (5098)
Now hiring (60)
Obesity (574)
Opinion (316)
Ovarian cancer (142)
Pain (173)
Pancreatic cancer (179)
Parkinson's disease (245)
Partnered (32)
Patents (430)
Patient recruitment (340)
Peanut (57)
People (66367)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23386)
Phase II (32895)
Phase III (24812)
Pipeline (2889)
Policy (302)
Postmarket research (3554)
Preclinical (10566)
Press Release (72)
Prostate cancer (205)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (713)
Real estate (7423)
Recruiting (79)
Regulatory (28145)
Reports (65)
Research institute (2695)
Resumes & cover letters (651)
Rett syndrome (17)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1064)
Venture capital (68)
Weight loss (405)
Women's health (61)
Worklife (21)
Date
Today (293)
Last 7 days (998)
Last 30 days (3300)
Last 365 days (33710)
2025 (28419)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (309)
Arkansas (14)
Asia (51077)
Australia (8980)
California (9906)
Canada (2941)
China (950)
Colorado (416)
Connecticut (437)
Delaware (285)
Europe (117398)
Florida (1456)
Georgia (325)
Hawaii (3)
Idaho (67)
Illinois (830)
India (55)
Indiana (486)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (22)
Maine (79)
Maryland (1320)
Massachusetts (7409)
Michigan (320)
Minnesota (588)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2741)
New Mexico (32)
New York (2666)
North Carolina (1445)
North Dakota (10)
Northern California (4559)
Ohio (310)
Oklahoma (22)
Oregon (51)
Pennsylvania (2044)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3778)
Tennessee (153)
Texas (1550)
United States (36377)
Utah (298)
Virginia (255)
Washington D.C. (84)
Washington State (842)
West Virginia (4)
Wisconsin (102)
Wyoming (2)
There are 862,883 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies
November 5, 2025
·
7 min read
Press Releases
Immuron IMM-529 IND approved by FDA
November 5, 2025
·
6 min read
Press Releases
U.S. FDA Grants Orphan Drug Designation to Leukogene Therapeutics’ M2T-CD33 (LTI-214) for the Treatment of Acute Myeloid Leukemia
November 5, 2025
·
2 min read
Press Releases
Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024
November 5, 2025
·
18 min read
Press Releases
Santhera Closes USD 13 Million Royalty Monetization Agreement
November 5, 2025
·
2 min read
Press Releases
Novo Nordisk’s sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues
November 5, 2025
·
4 min read
Press Releases
AVEROA Receives UK MHRA Approval for XOANACYL®, an Oral Therapy Targeting Key Complications of Chronic Kidney Disease (CKD)
November 5, 2025
·
5 min read
Press Releases
LIfT BioSciences to present preclinical data on its first-in-class Immunomodulatory Alpha Neutrophils at the 40th Society for Immunotherapy of Cancer
November 5, 2025
·
2 min read
Press Releases
Interim Report July - September 2025
November 5, 2025
·
8 min read
Press Releases
CelLBxHealth PLC Presents Proof-of-Concept Study
November 5, 2025
·
4 min read
1 of 86,289
Next
